The Africa Center for Disease Control (AfricaCDC) has explained that the Johnson and Johnson (J&J) vaccine was chosen for the continent because ‘it is a single-shot vaccine, with a long shelf-life and partly manufactured on the African continent. “First of all, as a single-shot vaccine, it is easier and cheaper… In "Breaking News" The South African pharmaceutical company will sell and distribute the vaccines, under its own packaging, across Africa. In "World News" Johnson & Johnson’s highly anticipated HIV vaccine failed to demonstrate adequate protection in a clinical trial involving more than 2,600 young women in sub-Saharan Africa, the company and US health authorities said Tuesday. Though the vaccine was found to be safe, with no serious side effects, its efficacy in preventing… In "Breaking News" Receive top breaking news, events, ideas, and more!